Lead exposure and cardiovascular disease - A systematic review

Environmental Health Perspectives

Volumn 115, Issue 3, 2007, Pages 472-482

  Navas Acien, Ana ^a   Guallar, Eliseo ^a,b   Silbergeld, Ellen K ^a   Rothenberg, Stephen J ^c,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Atherosclerosis; Blood pressure; Cardiovascular disease; Heart rate variability; Hypertension; Lead; Systematic review

Indexed keywords

LEAD;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CITATION ANALYSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; INFORMATION RETRIEVAL; LEAD BLOOD LEVEL; LEAD POISONING; MECHANOCARDIOGRAPHY; MEDICAL INFORMATION; MEDICAL RESEARCH; MORTALITY; OBSERVATIONAL STUDY; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PERIPHERAL VASCULAR DISEASE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; SYSTEMATIC REVIEW;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; LEAD;

EID: 34147103505     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9785     Document Type: Review

References (121)

1. Agency for Toxic Substances and Disease Registry. 1999. Toxicological Profile for Lead. Atlanta:Agency for Toxic Substances and Disease Registry.
2. Aiba Y, Ohshiba S, Horiguchi S, Morioka I, Miyashita K, Kiyota I, et al. 1999. Peripheral hemodynamics evaluated by acceleration plethysmography in workers exposed to lead. Ind Health 37:3-8.
3. Alexieva ZV, Burilkov T, Useva G. 1981. Studies on death causes among the workers from non-ferrous metallurgy. Hig Zdraveopoz 24:136-140.
4. Andrzejak R, Poreba R, Derkacz A. 2004. Effect of chronic lead poisoning on the parameters of heart rate variability. Med Pr 55:139-144.
5. Appel LJ, Robinson KA, Guallar E, Erlinger T, Masood SO, Jehn M, Fleisher L, et al. 2002. AHRQ Evidence Report No. 63. Utility of Blood Pressure Monitoring Outside the Clinic Setting. Rockville, MD:Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.
6. Arrighi HM, Hertz-Picciotto I. 1994. The evolving concept of the healthy worker survivor effect. Epidemiology 5:189-196.
7. Beck B, Steinmetz-Beck A. 2005. Echocardiographic evaluation of left ventricular function in persons with chronic proffesional exposure to lead. Adv Clin Exp Med 14:905-915.
8. Belli S, Comba P, Germani D, Grignoli M, Lagorio S, Paganoni R, et al 1989. Mortality among lead-zinc miners in Val Seriana. Med Lav 80:467-478.
9. Bhatnagar A. 2006. Environmental cardiology: studying mechanistic links between pollution and heart disease, Circ Res 99:692-705.
10. Böckelmann I, Pfister EA, McGauran N, Robra BP. 2002. Assessing the suitability of cross-sectional and longitudinal cardiac rhythm tests with regard to identifying effects of occupational chronic lead exposure. J Occup Environ Med 44:59-65
11. Carmignani M, Boscolo P, Poma A, Volpe AR. 1999, Kininergic system and arterial hypertension following chronic exposure to inorganic lead. Immunopharmacology 44:105-110.
12. Carta P, Aru G, Cadeddu C, Nieddu V, Polizzi M, Nurchis P, et al 2003. Lung cancer mortality among workers of a Sardinian lead smelter, G Ital Med Lav Ergon 25:17-18.
13. Chang HR, Tsao DA, Yu HS, Ho CK. 2005. The change of (beta)-adrenergic system after cessation of lead exposure. Toxicology 207:73-80.
14. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. 2001. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol 153:164-171.
15. Cheng Y, Schwartz J, Vokonas PS, Weiss ST, Aro A, Hu H. 1998. Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study). Am J Cardiol 82:594-599.
16. Choi BC. 1992. Definition, sources, magnitude, effect modifiers, and strategies of reduction of the healthy worker effect. J Occup Med 34:979-988.
17. Cocco P, Hua F, Boffetta P, Carta P, Flore C, Flore V, et al. 1997. Mortality of Italian lead smelter workers. Scand J Work Environ Health 23:15-23.
18. Cocco PL, Carta P, Belli S, Picchiri GF, Flore MV. 1994. Mortality of Sardinian lead and zinc miners: 1960-88. Occup Environ Med 51:674-682
19. Cooper WC, Wong O, Kheifets L. 1985. Mortality among employees of lead battery plants and lead-producing plants, 1947-1980. Scand J Work Environ Health 11:331-345.
20. Davies JM. 1984. Long term mortality study of chromate pigment workers who suffered lead poisoning. Br J Ind Med 41:170-178.
21. Ding Y, Vaziri ND, Gonick HC. 1998. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, super-oxide dismutase, and nitroprusside. Environ Res 76:107-113.
22. Dingwall-Fordyce I, Lane RE. 1963. A follow-up study of lead workers, Br J Ind Med 20:313-315.
23. Dulskiene V. 2003. Environmental pollution with lead and myocardial infarction morbidity. Medicina (Kaunas) 39:884-888.
24. Dursun N, Arifoglu C, Suer C, Keskinol L. 2005. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels. Biol Trace Elem Res 104:141-149.
25. Egger M, Davey Smith G, Altman DG. 2001 Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd ed. London: BMJ Books.
26. Ekong EB, Jaar BG, Weaver VM. 2006. Lead-related nephrotocixity: a review of the epidemiologic evidence. Kidney Int 70:2074-2084.
27. Farmand F, Ehdaie A, Roberts CK, Sindhu RK. 2005. Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase. Environ Res 98:33-39.
28. Fujiwara Y, Kaji T, Yamamoto C, Sakamoto M, Kozuka H. 1995. Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells. Toxicology 98:105-10.
29. Gajek J, Zysko D, Chlebda E. 2004. Heart rate variability in workers chronically exposed to lead. Kardiol Pol 61:21-30.
30. Gatagonova TM. 1995a. Changes of regional hemodynamics in workers engaged in lead manufacture. Gigiena I Sanitariya 2:16-17.
31. Gatagonova TM. 1995b. Bioelectrical activity of the myocardium and cardiac pump function in workers engaged in lead production. Gig Sanit 3:16-19.
32. Gatagonova TM. 1995c. Exercise tolerance and adaptation reserve of the myocardium in workers of lead enterprises. Gig Sanit 4:13-14.
33. Gatagonova TM. 1995d. Functional state of the cardiovascular system in workers employed in lead production, Med Tr Prom Ekol 1:15-22.
34. Gennart JP, Bernard A, Lauwerys R. 1992. Assessment of thyroid, testes, kidney and autonomic nervous system function in lead-exposed workers. Int Arch Occup Environ Health 64:49-57.
35. Gerhardsson L, Englyst V, Lundstrom NG, Nordberg G, Sandberg S, Steinvall F. 1995. Lead in tissues of deceased lead smelter workers. J Trace Elem Med Biol 9:136-143.
36. Gerr F, Letz R, Stokes L, Chettle D, McNeill F, Kaye W. 2002. Association between bone lead concentration and blood pressure among young adults. Am J Ind Med 42:98-106.
37. Glenn BS, Stewart WF, Links JM, Todd AC, Schwartz BS. 2003. The longitudinal association of lead with blood pressure. Epidemiology 14:30-36.
38. Greenland S. 1987. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1-30.
39. Gustavsson P, Plato N, Hallqvist J, Hogstedt C, Lewne M, Reuterwall C, et al. 2001. A population-based case-referent study of myocardial infarction and occupational exposure to motor exhaust, other combustion products, organic solvents, lead, and dynamite. Stockholm Heart Epidemiology Program (SHEEP) Study Group. Epidemiology 12:222-228.
40. Heo Y, Parsons PJ, Lawrence DA. 1996. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol 138:149-157.
41. Hertz-Picciotto I, Croft J. 1993. Review of the relation between blood lead and blood pressure. Epidemiol Rev 15:352-373.
42. Howe GR, Chiarelli AM, Lindsay JP. 1988. Components and modifiers of the healthy worker effect: evidence from three occupational cohorts and implications for industrial compensation. Am J Epidemiol 128:1364-1375.
43. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, et al. 1996. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 275:1171-1176.
44. Hu H, Shin R, Rothenberg S, Schwartz BS. 2007. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 115:455-462.
45. Ishida M, Ishizaki M, Yamada Y. 1996. Decreases in postural change in finger blood flow in ceramic painters chronically exposed to low level lead. Am J Ind Med 29:547-553.
46. Jhun HJ, Kim H, Paek DM. 2005. The association between blood metal concentrations and heart rate variability: a cross-sectional study. Int Arch Occup Environ Health 78:243-247.
47. Kasperczyk S, Przywara-Chowaniec B, Kasperczyk A, Rykaczewska-Czerwinska M, Wodniecki J, Birkner E, et al. 2005. Function of heart muscle in people chronically exposed to lead. Ann Agric Environ Med 12:207-210.
48. Kirkby H, Gyntelberg F. 1985. Blood pressure and other cardiovascular risk factors of long-term exposure to lead. Scand J Work Environ Health 11:15-19.
49. Korrick SA, Hunter DJ, Rotnitzky A, Hu H, Speizer FE. 1999. Lead and hypertension in a sample of middle-aged women. Am J Public Health 89:330-335.
50. Kosmala W, Kuliczkowski W, Jolda-Mydlowska B, Przewlocka-Kosmala M, Kucharski W, Antonowicz-Juchniewicz J. 2004. Relation between heavy metals and left ventricular diastolic function in patients with coronary artery disease. Toxicol Mech Methods 14:177-182.
51. Kosmider S. 1968. Relations between heavy metal poisoning and atheromatosis as well as cardiovacular disorders. Z Gesamte Hyg 14:355-360.
52. Kosmider S, Kowalski W, Smolarz W, Stradowski J. 1965. Circulatory examinations in chronic industrial lead poisoning. Zentralbl Arbeitsmed 15:233-237.
53. Kosmider S, Petelenz T. 1961. Electrocardiographic studies in cases of chronic occupational lead poisoning. Pol Arch Med Wewn 31:1349-1357.
54. Kosmider S, Petelenz T. 1962. Electrocardiographic changes in older subjects with chronic occupational lead poisoning. Pol Arch Med Wewn 32:437-42.:437-442.
55. Kromhout D. 1988. Blood lead and coronary heart disease risk among elderly men in Zutphen, The Netherlands, Environ Health Perspect 78:43-46.
56. Kromhout D, Wibowo AAE, Herber RFM. 1985. Trace metals and coronary heart disease risk indicators in 152 elderly men (The Zutphen Study). Am J Epidemiol 122:378-385.
57. Krotkiewski A, Juskowa J, Koziolowa H. 1964. Electrocardiographic changes in patients with lead poisoning. Pol Arch Med Wewn 34:1223-1228.
58. Lancéreaux E. 1881, Nephrite et arthrite saturnine; coincidences de ces affections; parallèle ave la néphrite et l'arthrite goutteuses. Transact Int Med Congr 2:193-202.
59. Lee BK, Lee GS, Stewart WF, Ahn KD, Simon D, Kelsey KT, et al. 2001. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 109:383-389.
60. Liao D, Cai J, Rosamond WD, Barnes RW, Hutchinson RG, Whitsel EA, et al. 1997, Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study. Am J Epidemiol 145:696-706.
61. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. 1988. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 260:652-656.
62. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. 2006. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747-1757.
63. Lorimer G. 1886. Saturnine gout, and its distinguishing marks. BMJ 2:163.
64. Lundstrom NG, Nordberg G, Englyst V, Gerhardsson L, Hagmar L, Jin T, et al. 1997. Cumulative lead exposure in relation to mortality and lung cancer morbidity in a cohort of primary smelter workers. Scand J Work Environ Health 23:24-30.
65. Lustberg M, Silbergeld E. 2002. Blood lead levels and mortality. Arch Intern Med 162:2443-2449.
66. Malcolm D. 1971. Prevention of long-term sequelae following the absorption of lead. Arch Environ Health 23:292-298.
67. Malcolm D, Barnett HA. 1982. A mortality study of lead workers 1925-76. Br J Ind Med 39:404-410.
68. Mansoor MA, Bergmark C, Haswell SJ, Savage IF, Evans PH, Berge RK, et al. 2000. Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem 46:385-391.
69. Martin D, Glass TA, Bandeen-Roche K, Todd AC, Shi W, Schwartz BS. 2006. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol 163:467-478.
70. McMichael AJ, Johnson HM. 1982. Long-term mortality profile of heavily-exposed lead smelter workers. J Occup Med 24: 375-378.
71. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. 2006. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 114:1388-1394.
72. Michaels D, Zoloth SR, Stern FB. 1991. Does low-level lead exposure increase risk of death? A mortality study of newspaper printers. Int J Epidemiol 20:978-983.
73. Minaii B, Towfighi Z, Soltaninejad K, Abdollahi M. 2002. Toxicity of lead acetate on rabbit arteries: a histological evaluation. Biomed Res (India) 13:125-128.
74. Møller L, Kristensen TS. 1992. Blood lead as a cardiovascular risk factor. Am J Epidemiol 136:1091-1100.
75. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. 2005. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 165:2155-2161.
76. Murata K, Araki S. 1991. Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation to peripheral nerve conduction: a study of R-R interval variability. Am J Ind Med 20:663-671.
77. Murata K, Araki S, Yokoyama K, Nomiyama K, Nomiyama H, Tao YX, et al. 1995. Autonomic and central nervous system effects of lead in female glass workers in China. Am J Ind Med 28(2):233-244.
78. Muzi G, Murgia N, Dell'Omo M, Fiordi T, Sposini F, Argentino A, et al. 2005. Effects of inorganic lead exposure on the autonomic nervous system and on the variability of heart rate among workers at a battery plant. G Ital Med Lav Ergon 27 (suppl 1):46-50.
79. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. 2004. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109:3196-3201.
80. Nawrot TS, Staessen JA. 2006. Low-level environmental exposure to lead unmasked as silent killer. Circulation 114: 1347-1349.
81. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. 2002. An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 16:123-131.
82. Niu Q, Li Z, Abbritti G. 1998. Study on the changes of heart-rate in lead-exposed workers. Wei Shang Yan Jiu 27:9-11.
83. Pan TC, Horng CJ, Lin SR, Lin TH, Huang CW. 1993. Simultaneous determination of Zn, Cd, Pb, and Cu in urine of patients with blackfoot disease using anodic stripping voltammetry. Biol Trace Elem Res 38:233-241.
84. Pocock SJ, Shaper AG, Ashby D, Delves HT, Clayton BE. 1988. The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ Health Perspect 78:23-30.
85. Pocock SJ, Shaper AG, Ashby D, Delves T, Whitehead TP. 1984. Blood lead concentration, blood pressure, and renal function. Br Men J (Clin Res Ed) 289:872-874.
86. Revis NW, Zinsmeister AR, Bull R. 1981. Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc Natl Acad Sci USA 78:6494-6498.
87. Robinson TR. 1974. 20-year mortality of tetraethyl lead workers. J Occup Med 15:601-605.
88. Rodriguez-Iturbe B, Sindhu RK, Quiroz Y, Vaziri ND. 2005. Chronic exposure to low doses of lead results in renal infiltration of immune cells, NF-kappaB activation, and overexpression of tubulointerstitial angiotensin II. Antioxid Redox Signal 7:1269-1274.
89. Rothenberg SJ, Kondrashov V, Manalo M, Jiang J, Cuellar R, Garcia M, et al. 2002. Increases in hypertension and blood pressure during pregnancy with increased bone lead levels. Am J Epidemiol 156:1079-1087.
90. Saric M. 1981. Ischemic heart disease, circulatory diseases and kidney diseases in a population living near a lead smelter. Arh Hig Rada Toksikol 32:3-19.
91. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM, 2006. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III Mortality Study. Environ Health Perspect 114:1538-41.
92. Schwartz BS, Lee BK, Lee GS, Stewart WF, Lee SS, Hwang KY, et al. 2001. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 153:453-464.
93. Schwartz BS, Stewart WF. 2000. Different associations of blood lead, meso 2,3-dimercaptosuccinic acid (DMSA)-chelatable lead, and tibial lead levels with blood pressure in 543 former organolead manufacturing workers. Arch Environ Health 55:85-92.
94. Schwartz J. 1988. The relationship between blood lead and blood pressure in the NHANES II survey. Environ Health Perspect 78:15-22.
95. Schwartz J. 1991. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect 91:71-75.
96. Schwartz J. 1995. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health 50:31-37.
97. Sharp DS, Becker CE, Smith AH. 1987. Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol 2:210-232.
98. Shcherbak EA. 1988. Effect of microclimate heating and occupational noise and their combination with lead aerosols on the incidence of cardiovascular diseases. Gig Tr Prof Zabol 11: 25-27.
99. Sheffet A, Thind I, Miller AM, Louria DB. 1982. Cancer mortality in a pigment plant utilizing lead and zinc chromates. Arch Environ Health 37:44-52.
100. Shih RA, Hu H, Weisskopf MG, Schwartz BS. 2007. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 115:483-492.
101. Sroczynski J, Biskupek K, Piotrowski J, Rudzki H. 1990. Effect of occupational exposure to lead, zinc and cadmium on various indicators of the circulatory system of metallurgical workers. Med Pr 41:152-158.
102. Sroczynski J, Urbanska-Bonenberg L, Twardowska-Saucha K, Bonkowska M. 1985. Health status of workers chronically exposed to lead. Pol Tyg Lek 40:221-223.
103. Staessen JA, Bulpitt CJ, Fagard R, Lauwerys RR, Roels H, Thijs L, et al. 1994. Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk 1:87-97.
104. Staessen JA, Roels H, Lauwerys RR, Amery A. 1995. Low-level lead exposure and blood pressure. J Hum Hypertens 9:303-328.
105. Steenland K, Selevan S, Landrigan P. 1992. The mortality of lead smelter workers: an update. Am J Public Health 82:1641-1644.
106. Stohs SJ, Bagchi D. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18:321-336.
107. Stozinic S, Colakovic B, 1980. Harmful effects of lead on the heart and blood vessels. Srp Arh Celok Lek 108:721-731.
108. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. 1996. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065.
109. Tepper A, Mueller C, Singal M, Sagar K. 2001. Blood pressure, left ventricular mass, and lead exposure in battery manufacturing workers. Am J Ind Med 40:63-72.
110. Teruya K, Sakurai H, Omae K, Higashi T, Muto T, Kaneko Y. 1991. Effect of lead on cardiac parasympathetic function. Int Arch Occup Environ Health 62:549-553.
111. Tollestrup K, Daling JR, Allard J. 1995. Mortality in a cohort of orchard workers exposed to lead arsenate pesticide spray. Arch Environ Health 50:221-229.
112. Tsai JL, Horng PH, Hwang TJ, Hsu JW, Horng CJ. 2004. Determination of urinary trace elements (arsenic, copper, cadmium, manganese, lead, zinc, selenium) in patients with Blackfoot disease. Arch Environ Health 59:686-692.
113. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, et al. 1996. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 94:2850-2855.
114. U.S. DHHS. 2004. The Health Consequences of Smoking: a Report of the Surgeon General. Atlanta:Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.
115. U.S. EPA (U.S. Environmental Protection Agency). 2006. Air Quality Criteria for Lead (Final). Available: http://cfpub.epa.gov/ncea/cfm/ recordisplay.cfm?deid=158823 [accessed 27 November 2006].
116. Vaziri ND, Ding Y, Ni Z. 2001. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 298:679-685.
117. Vigdortchik 1935. Lead intoxication in the etiology of hypertonia. J Ind Hygiene 17:1-6.
118. Weinhold B. 2004. Environmental cardiology: getting to the heart of the matter. Environ Health Perspect 112:A880-A887.
119. Weiss ST, Munoz A, Stein A, Sparrow D, Speizer FE. 1986. The relationship of blood lead to blood pressure in a longitudinal study of working men. Am J Epidemiol 123:800-808.
120. Wilczynska U, Szeszenia-Dabrowska N, Sobala W. 1998. Mortality of men with occupational lead poisoning in Poland. Med Pr 49:113-128.
121. Zou HJ, Ding Y, Huang KL, Xu ML, Tang GF, Wu MH, et al. 1995. Effects of lead on systolic and diastolic cardiac functions. Biomed Environ Sci 8:281-288.